论文部分内容阅读
1987～1993年,我们应用胎盘免疫调节肽治疗病毒性肝炎138例,其中乙型慢性活动性肝炎92例,现报告如下。 1.临床资料:男性59例,女性33例,年龄5～65岁,平均24岁。均有乏力、恶心、厌油及肝功不同程度损害,DHA皮试直径平均<11.5mm。均根据1984年全国病毒性肝炎学术会议标准确诊。治愈标准为:自觉症状消失,肝脾肿大无变化或回缩,无压痛叩痛,肝功正常,一般情况好转,能参加一般体力劳动,观察2年以上,病情稳定并能担任正常工作。显效:自觉症状消失,肝脾肿大稳定不变,肝功正常。好转:自觉症状基本消失,肝脾肿大无变化,无明显压痛及叩痛,肝功正常或轻微异常。 2.方法与结果:胎盘免疫调节肽用量:第1周
From 1987 to 1993, we applied placental immunomodulatory peptides in the treatment of viral hepatitis in 138 cases, of which 92 cases of chronic active hepatitis B, are as follows. 1. Clinical data: 59 males and 33 females, aged 5 to 65 years, mean 24 years old. All have fatigue, nausea, tired of oil and liver function damage to varying degrees, DHA skin test average diameter <11.5mm. According to the 1984 National Conference on viral hepatitis diagnostic criteria. The standard of cure is: disappearance of subjective symptoms, no change or contraction of hepatosplenomegaly, tenderness and percussion pain, normal liver function, general improvement, can participate in general manual labor, observe more than 2 years, stable condition and can serve as normal work. Markedly effective: symptoms disappear, stable hepatosplenomegaly, normal liver function. Improvement: subjective symptoms disappeared, no change in hepatosplenomegaly, no significant tenderness and percussion pain, normal or mild abnormal liver function. 2. Methods and Results: Placental immunomodulatory peptide dosage: the first week